average industry
DESCRIPTION
DataTRANSCRIPT
2014 2013ROCE 1 Astrazeneca Plc 0.06 0.11
2 Glaxosmithkline Plc 0.62 0.33
3 Shire Plc 0.39
4 Hikma Pharmaceuticals Plc 0.21 0.12
5 Vectura group -0.01 -0.04
6 Dechra Pharmaceuticals 0.29 0.10
Avg ROCE 1st half 0.36 0.22
Avg ROCE 2nd half 0.16 0.06
RNOA 1 Astrazeneca Plc 0.07 0.09
2 Glaxosmithkline Plc 0.12 0.11
3 Shire Plc 0.52
4 Hikma Pharmaceuticals Plc 0.18 0.10
5 Vectura group 0.00 0.00
6 Dechra Pharmaceuticals 0.26 0.08
Avg RNOA 1st half 0.24 0.10
Avg RNOA 2nd half 0.15 0.06
FLEV 1 Astrazeneca Plc 0.51 0.41
2 Glaxosmithkline Plc 4.36 2.15
3 Shire Plc -0.25
4 Hikma Pharmaceuticals Plc 0.33 0.58
5 Vectura group 0.00 0.00
6 Dechra Pharmaceuticals 0.16 0.72
Avg FLEV 1st half 1.54 1.28
Avg FLEV 2nd half 0.16 0.43
SPREAD 1 Astrazeneca Plc -0.02 0.05
2 Glaxosmithkline Plc 0.11 0.103 Shire Plc 0.534 Hikma Pharmaceuticals Plc 0.09 0.045 Vectura group 0.00 0.006 Dechra Pharmaceuticals 0.19 0.04
Avg SPREAD 1st half 0.21 0.07Avg SPREAD 2nd half 0.09 0.03
2012 2011 2010 2014
0.26 0.43 0.35 Glaxosmithkline Plc 0.62
0.37 0.26 0.21 Avg ROCE 1st half 0.36
0.20 0.27 0.24 Avg ROCE 2nd half 0.16
0.10 0.13 0.11
-0.03 -0.06 -0.07
0.08 0.14 0.15
0.28 0.32 0.27
0.05 0.07 0.07
0.20 0.46 0.39 2014
0.11 0.10 0.08 Glaxosmithkline Plc 0.12
0.16 0.21 0.17 Avg RNOA 1st half 0.24
0.07 0.12 0.10 Avg RNOA 2nd half 0.15
0.00 0.00 0.00
0.05 0.10 0.13
0.15 0.25 0.21
0.04 0.07 0.08
0.40 -0.04 -0.07 2014
2.66 1.82 1.67 Glaxosmithkline Plc 4.36
0.29 0.35 0.45 Avg FLEV 1st half 1.54
0.62 0.21 0.25 Avg FLEV 2nd half 0.16
0.00 0.00 0.00
0.78 0.66 0.39
1.12 0.71 0.68
0.46 0.29 0.21
0.16 0.76 0.60 20140.09 0.09 0.07 Glaxosmithkline Plc 0.110.13 0.18 0.15 Avg SPREAD 1st half 0.210.05 0.09 0.06 Avg SPREAD 2nd half 0.090.00 0.00 0.000.03 0.07 0.070.13 0.34 0.270.03 0.05 0.04
2013 2012 2011 2010
0.33 0.37 0.26 0.21
0.22 0.28 0.32 0.27
0.06 0.05 0.07 0.07
2013 2012 2011 2010
0.11 0.11 0.10 0.08
0.10 0.15 0.25 0.21
0.06 0.04 0.07 0.08
2013 2012 2011 2010
2.15 2.66 1.82 1.67
1.28 1.12 0.71 0.68
0.43 0.46 0.29 0.21
2013 2012 2011 20100.10 0.09 0.09 0.070.07 0.13 0.34 0.270.03 0.03 0.05 0.04
2014 2013 2012 2011 20100.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
ROCE
Glaxosmithkline Plc Avg ROCE 1st half Avg ROCE 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
RNOA
Glaxosmithkline Plc Avg RNOA 1st half Avg RNOA 2nd half
2014 2013 2012 2011 20100.000.501.001.502.002.503.003.504.004.505.00
FLEV
Glaxosmithkline Plc Avg FLEV 1st half Avg FLEV 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
SPREAD
Glaxosmithkline Plc Avg SPREAD 1st half Avg SPREAD 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
RNOA
Glaxosmithkline Plc Avg RNOA 1st half Avg RNOA 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
SPREAD
Glaxosmithkline Plc Avg SPREAD 1st half Avg SPREAD 2nd half
2014 2013 2012 2011ROCE 1 Pfizer Inc 0.13 0.10 0.10
2 Johnson&Johnson 0.23 0.19 0.17 0.17
3 Merk&Company Inc 0.16 0.17
4 Actavis Plc -0.06 -0.08 0.03 0.07
5 Bristol Myers Squibb Company 0.13 0.17 0.14 0.236 Abbvie Inc 1.02 0.92 1.57 0.29
Avg ROCE 1st half 0.17 0.19 0.14 0.14
Avg ROCE 2nd half 0.37 0.34 0.58 0.20
RNOA 1 Pfizer 0.13 0.11 0.12
2 Johnson&Johnson 0.29 0.21 0.17 0.22
3 Merk&Company Inc 0.20 0.09 0.09
4 Actavis Public limited -0.03 -0.03 0.02 0.07
5 Bristol myers squibb company 0.11 0.12 0.13 0.296 Abbvie 0.11 0.23 0.32 0.30
Avg RNOA 1st half 0.20 0.21 0.12 0.15Avg RNOA 2nd half 0.06 0.11 0.15 0.22
FLEV 1 Pfizer 0.06 0.08 0.00 0.19
2 Johnson&Johnson -0.17 -0.09 -0.03 -0.17
3 Merk&Company Inc 0.27 0.47 0.33 0.29
4 Actavis Public limited 0.55 0.95 1.68 0.32
5 Bristol myers squibb company 0.39 0.49 0.46 0.166 Abbvie 8.48 3.21 4.04 -0.05
Avg FLEV 1st half 0.05 0.15 0.10 0.10Avg FLEV 2nd half 3.14 1.55 2.06 0.14
SPREAD 1 Pfizer -0.05 -0.08
2 Johnson&Johnson 0.32 0.27 0.35 0.31
3 Merk&Company Inc 0.18 0.07 0.06
4 Actavis Public limited -0.05 -0.05 0.00 0.025 Bristol myers squibb company 0.08 0.10 0.12 0.276 Abbvie 0.11 0.21 0.31 0.27
Avg SPREAD 1st half 0.15 0.27 0.21 0.10Avg SPREAD 2nd half 0.04 0.09 0.14 0.19
2010 2014 2013 2012 2011
0.09 Johnson&Johnson 0.23 0.19 0.17 0.17
0.24 Avg ROCE 1st half 0.17 0.19 0.14 0.14
Avg ROCE 2nd half 0.37 0.34 0.58 0.20
0.06
0.200.270.16
0.17
0.09 2014 2013 2012 2011
0.28 Johnson&Johnson 0.29 0.21 0.17 0.22
Avg RNOA 1st half 0.20 0.21 0.12 0.15
0.06 Avg RNOA 2nd half 0.06 0.11 0.15 0.22
0.260.27
0.190.19
0.20 2014 2013 2012 2011
-0.15 Johnson&Johnson -0.17 -0.09 -0.03 -0.17
Avg FLEV 1st half 0.05 0.15 0.10 0.10
0.31 Avg FLEV 2nd half 3.14 1.55 2.06 0.14
0.160.00
0.020.15
0.02 2014 2013 2012 2011
0.32 Johnson&Johnson 0.32 0.27 0.35 0.31
Avg SPREAD 1st half 0.15 0.27 0.21 0.10
-0.01 Avg SPREAD 2nd half 0.04 0.09 0.14 0.190.190.270.170.15
2010
0.24
0.16
0.17
2010
0.28
0.19
0.19
2010
-0.15
0.02
0.15
2010
0.32
0.17
0.15
2014 2013 2012 2011 20100.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
ROCE
Johnson&Johnson Avg ROCE 1st half Avg ROCE 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
RNOA
Johnson&Johnson Avg RNOA 1st half Avg RNOA 2nd half
2014 2013 2012 2011 2010-0.50
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
FLEV
Johnson&Johnson Avg FLEV 1st half Avg FLEV 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
SPREAD
Johnson&Johnson Avg SPREAD 1st halfAvg SPREAD 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
RNOA
Johnson&Johnson Avg RNOA 1st half Avg RNOA 2nd half
2014 2013 2012 2011 20100.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
SPREAD
Johnson&Johnson Avg SPREAD 1st halfAvg SPREAD 2nd half